Verrica Pharmaceuticals (VRCA) Cash & Equivalents (2017 - 2026)
Verrica Pharmaceuticals (VRCA) posted Cash & Equivalents of $11.2 million for Q2 2026, down 27.3% from $15.4 million a year earlier and down 45.6% from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Verrica Pharmaceuticals' Cash & Equivalents came in at $30.15 million, down 34.9% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
- In prior years, Verrica Pharmaceuticals' Cash & Equivalents was $46.33 million in FY2024 (-33.4%), $69.55 million in FY2023 (+102.9%), $34.27 million in FY2022 (+117.6%) and $15.75 million in FY2021 (+47.4%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q4 2020.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last ten quarters, with an average decline of 37.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2023, with growth of 159.6%; the weakest was Q3 2024, with a decline of 72.7%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $20.6 million (Q1 2026), $30.15 million (Q4 2025) and $21.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Verrica Pharmaceuticals | 60.47 Mn | -22.58 Mn | 5.43 Mn | 11.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20 Mn |
| Mar 31, 2026 | 20.60 Mn |
| Dec 31, 2025 | 30.15 Mn |
| Sep 30, 2025 | 21.10 Mn |
| Jun 30, 2025 | 15.40 Mn |
| Mar 31, 2025 | 29.60 Mn |
| Dec 31, 2024 | 46.33 Mn |
| Sep 30, 2024 | 23.00 Mn |
| Jun 30, 2024 | 31.93 Mn |
| Mar 31, 2024 | 48.94 Mn |
| Dec 31, 2023 | 69.55 Mn |
| Sep 30, 2023 | 84.31 Mn |
| Jun 30, 2023 | 55.14 Mn |
| Mar 31, 2023 | 60.00 Mn |
| Dec 31, 2022 | 34.27 Mn |
| Sep 30, 2022 | 32.47 Mn |
| Jun 30, 2022 | 45.43 Mn |
| Mar 31, 2022 | 50.41 Mn |
| Dec 31, 2021 | 15.75 Mn |
| Sep 30, 2021 | 20.44 Mn |
API Access
Verrica Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();